These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27027958)

  • 1. Drug Development and Biologics in Asthma. A New Era.
    Doyle R
    Ann Am Thorac Soc; 2016 Mar; 13 Suppl 1():S83-4. PubMed ID: 27027958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.
    Huffaker MF; Phipatanakul W
    Immunol Allergy Clin North Am; 2015 Feb; 35(1):129-44. PubMed ID: 25459581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologics in asthma--the next step toward personalized treatment.
    Darveaux J; Busse WW
    J Allergy Clin Immunol Pract; 2015; 3(2):152-60; quiz 161. PubMed ID: 25754716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the current role of biologics in the management of patients with severe refractory asthma?
    Draikiwicz S; Oppenheimer J
    Ann Allergy Asthma Immunol; 2016 May; 116(5):383-7. PubMed ID: 27153737
    [No Abstract]   [Full Text] [Related]  

  • 5. Asthma treatments: new and emerging therapies.
    Calhoun KH
    Int Forum Allergy Rhinol; 2015 Sep; 5 Suppl 1():S76-81. PubMed ID: 26335840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics for paediatric severe asthma: trick or TREAT?
    Saglani S; Bush A; Carroll W; Cunningham S; Fleming L; Gaillard E; Gupta A; Murray C; Nagakumar P; Paton J; Roberts G; Seddon P; Sinha I
    Lancet Respir Med; 2019 Apr; 7(4):294-296. PubMed ID: 30824361
    [No Abstract]   [Full Text] [Related]  

  • 7. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers.
    Santus P; Saad M; Damiani G; Patella V; Radovanovic D
    Pharmacol Res; 2019 Aug; 146():104296. PubMed ID: 31173886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies and opportunities in severe asthma.
    Humbert M; Busse W; Hanania NA
    Curr Opin Pulm Med; 2018 Jan; 24(1):83-93. PubMed ID: 29059087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe T2-high asthma in the biologics era: European experts' opinion.
    Pavord I; Bahmer T; Braido F; Cosío BG; Humbert M; Idzko M; Adamek L
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New perspectives of childhood asthma treatment with biologics.
    Just J; Deschildre A; Lejeune S; Amat F
    Pediatr Allergy Immunol; 2019 Mar; 30(2):159-171. PubMed ID: 30444939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics in Asthma: Emerging Biologics.
    Desai B; Adrish M; Mohan A; Lugogo NL
    Immunol Allergy Clin North Am; 2024 Nov; 44(4):751-763. PubMed ID: 39389722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic and New Therapies in Asthma.
    Tabatabaian F; Ledford DK; Casale TB
    Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on emerging drugs for asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):37-42. PubMed ID: 22292562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma biologics: Underuse, overuse, and best use?
    Rank MA; Oppenheimer JJ
    Ann Allergy Asthma Immunol; 2019 Apr; 122(4):358-359. PubMed ID: 30578858
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical use of biologics for asthma treatment by allergy specialists: A questionnaire survey.
    Kuruvilla M; Ariue B; Oppenheimer JJ; Singh U; Bernstein JA
    Ann Allergy Asthma Immunol; 2020 Oct; 125(4):433-439. PubMed ID: 32629016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching between biologics in severe asthma patients. When the first choice is not proven to be the best.
    Papaioannou AI; Fouka E; Papakosta D; Papiris S; Loukides S
    Clin Exp Allergy; 2021 Feb; 51(2):221-227. PubMed ID: 33305478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for new and emerging therapeutics in severe asthma: the role of biologics.
    Kepil Özdemir S; Bavbek S
    Expert Rev Respir Med; 2017 Jun; 11(6):505-512. PubMed ID: 28464704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe asthma and biologics: Data are good, listening to patients is better.
    Bukstein DA; Guerra DG
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):285-286. PubMed ID: 34479728
    [No Abstract]   [Full Text] [Related]  

  • 20. Biologics for severe asthma-Which, when and why?
    Shah PA; Brightling C
    Respirology; 2023 Aug; 28(8):709-721. PubMed ID: 37222237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.